Literature DB >> 27354446

Genomic Changes Associated with the Loss of Nocardia brasiliensis Virulence in Mice after 200 In Vitro Passages.

Carolina Gonzalez-Carrillo1, Cassandra Millan-Sauceda1, Hector Gerardo Lozano-Garza1, Rocio Ortiz-Lopez2, Ramiro Elizondo-Gonzalez3, Oliverio Welsh1, Jorge Ocampo-Candiani1, Lucio Vera-Cabrera4.   

Abstract

Nocardia species, particularly Nocardia brasiliensis, are etiologic agents of mycetoma, a chronic subcutaneous infection. Until now, little has been known about the pathogenic mechanisms involved in nocardial infection. Traditionally, subculture in rich media has been a simple way to induce attenuation. In this work, we report the changes in virulence toward mice and in genomic constitution of N. brasiliensis produced after 200 continuous subcultures in brain heart infusion (BHI) medium (P-200 strain). The ability of the N. brasiliensis P-200 strain to produce experimental infection was tested using BALB/c mice. P-200 was also used to immunize mice to determine whether it could induce resistance against a challenge with a nonsubcultured isolate (P-0). Comparative proteomic analysis between N. brasiliensis P-0 and P-200 was performed by two-dimensional (2-D) electrophoresis, and the genome sequence was obtained through Roche 454 sequence analysis. Virulence in BALB/c mice was completely lost, and BALB/c mice immunized with P-200 bacterial cells were resistant to mycetoma production by the nonsubcultured strain. Whole-genome sequence analysis revealed that P-200 lost a total of 262,913 bp distributed in 19 deleted regions, involving a total of 213 open reading frames (ORFs). The deleted genes included those encoding bacterial virulence factors, e.g., catalase, nitrate reductase enzymes, and a group of mammalian cell entry (MCE) family proteins, which may explain the loss of virulence of the isolate. Thus, completely attenuated N. brasiliensis was obtained after 200 passages in BHI medium, and putative Nocardia virulence genes were identified for the first time.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27354446      PMCID: PMC4995893          DOI: 10.1128/IAI.00329-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Genome evolution and adaptation in a long-term experiment with Escherichia coli.

Authors:  Jeffrey E Barrick; Dong Su Yu; Sung Ho Yoon; Haeyoung Jeong; Tae Kwang Oh; Dominique Schneider; Richard E Lenski; Jihyun F Kim
Journal:  Nature       Date:  2009-10-18       Impact factor: 49.962

2.  Has BCG attenuated to impotence?

Authors:  M A Behr; P M Small
Journal:  Nature       Date:  1997-09-11       Impact factor: 49.962

3.  Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.

Authors:  Alexander S Pym; Priscille Brodin; Roland Brosch; Michel Huerre; Stewart T Cole
Journal:  Mol Microbiol       Date:  2002-11       Impact factor: 3.501

4.  Nocardia brasiliensis cell wall lipids modulate macrophage and dendritic responses that favor development of experimental actinomycetoma in BALB/c mice.

Authors:  J Humberto Trevino-Villarreal; Lucio Vera-Cabrera; Pedro L Valero-Guillén; Mario C Salinas-Carmona
Journal:  Infect Immun       Date:  2012-07-30       Impact factor: 3.441

5.  Decrease of virulence for BALB/c mice produced by continuous subculturing of Nocardia brasiliensis.

Authors:  Janeth A Almaguer-Chávez; Oliverio Welsh; Hector G Lozano-Garza; Salvador Said-Fernández; Víktor J Romero-Díaz; Jorge Ocampo-Candiani; Lucio Vera-Cabrera
Journal:  BMC Infect Dis       Date:  2011-10-26       Impact factor: 3.090

6.  In Vivo Activity of the Benzothiazinones PBTZ169 and BTZ043 against Nocardia brasiliensis.

Authors:  Norma Alejandra González-Martínez; Hector Gerardo Lozano-Garza; Jorge Castro-Garza; Alexandra De Osio-Cortez; Javier Vargas-Villarreal; Norma Cavazos-Rocha; Jorge Ocampo-Candiani; Vadim Makarov; Stewart T Cole; Lucio Vera-Cabrera
Journal:  PLoS Negl Trop Dis       Date:  2015-10-16

7.  Complete genome sequence analysis of Nocardia brasiliensis HUJEG-1 reveals a saprobic lifestyle and the genes needed for human pathogenesis.

Authors:  Lucio Vera-Cabrera; Rocio Ortiz-Lopez; Ramiro Elizondo-Gonzalez; Jorge Ocampo-Candiani
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

8.  Wild type measles virus attenuation independent of type I IFN.

Authors:  Johan Druelle; Caroline I Sellin; Diane Waku-Kouomou; Branka Horvat; Fabian T Wild
Journal:  Virol J       Date:  2008-02-03       Impact factor: 4.099

9.  Nocardia brasiliensis induces formation of foamy macrophages and dendritic cells in vitro and in vivo.

Authors:  Irene Meester; Adrian Geovanni Rosas-Taraco; Mario Cesar Salinas-Carmona
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

Review 10.  Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis.

Authors:  A Roy; M Eisenhut; R J Harris; L C Rodrigues; S Sridhar; S Habermann; L Snell; P Mangtani; I Adetifa; A Lalvani; I Abubakar
Journal:  BMJ       Date:  2014-08-05
View more
  2 in total

1.  Analysis of the complete genome sequence of Nocardia seriolae UTF1, the causative agent of fish nocardiosis: The first reference genome sequence of the fish pathogenic Nocardia species.

Authors:  Motoshige Yasuike; Issei Nishiki; Yuki Iwasaki; Yoji Nakamura; Atushi Fujiwara; Yoshiko Shimahara; Takashi Kamaishi; Terutoyo Yoshida; Satoshi Nagai; Takanori Kobayashi; Masaya Katoh
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

2.  Mce1C and Mce1D facilitate N. farcinica invasion of host cells and suppress immune responses by inhibiting innate signaling pathways.

Authors:  Xingzhao Ji; Xiujuan Zhang; Lina Sun; Xuexin Hou; Jingdong Song; Xiaoluo Tan; Han Song; Xiaotong Qiu; Minghui Li; Lu Tang; Lichao Han; Zhenjun Li
Journal:  Sci Rep       Date:  2020-09-10       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.